Feasibility study of adjuvant chemotherapy with nab-paclitaxel and carboplatin in patients with completely resected pathological IB squamous cell lung cancer, II and IIIA non-small cell lung cancer
Not Applicable
Recruiting
- Conditions
- on-small cell lung cancer
- Registration Number
- JPRN-UMIN000012505
- Lead Sponsor
- Dokkyo Medical University department of General thoracic surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1) Not recovered from surgical complications 2) Active infection such as bacterial infection 3) Patients with interstitial pneumonitis or pulmonary fibrosis, as determined by chest CT 4) patients with myocardial infraction within 6 months 5) Patients with uncontrolled complications 6) With the history of hypersensitivity for nab-paclitaxel or CBDCA 7) Grade 2 or greater peripheral neuropathy 8) Active concomitant malignancy 9) Pregnant females, nursing mothers, possibly pregnant females, females wishing to become pregnant and Males that are currently attempting to produce a pregnancy 10) Other conditions not suitable for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The completion rate
- Secondary Outcome Measures
Name Time Method toxicities, disease-free survival, overall survival, recurrence type